Skip Navigation

QJM 2009 102(9):591-592; doi:10.1093/qjmed/hcp117
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bannon, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bannon, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Elements: In this month's issue

The first 10% of the full text of this article appears below.

Morbidity resulting from snakebite represents a significant global healthcare burden, especially in developing tropical countries. It is impossible to gain precise data on this subject however, it has been estimated that over 5 million instances of snakebite occur each year worldwide resulting in 125,000 deaths. The death rate from snakebite is higher in densely populated countries particularly in sub-Saharan Africa and South East Asia. The United Kingdom has just one native venomous species, the Common Adder or Vipera Berus. About 100–200 Adder bites are . . . [Full Text of this Article]

Michael Bannon

Editor, QJM


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?